Russell Frank Company’s Puma Biotechnology PBYI Stock Holding History

Russell Frank Company’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.17M	Sell	176,202 -38,544	-18%	-$1.74M	0.01%	1308
2015 Q4	$16.4M	Sell	214,746 -20,787	-9%	-$1.63M	0.03%	662
2015 Q3	$17.7M	Buy	235,533 +103,121	+78%	+$9.75M	0.03%	608
2015 Q2	$15.5M	Buy	132,412 +126,419	+2,109%	+$22.9M	0.02%	755
2015 Q1	$1.41M	Buy	5,993 +423	+8%	+$90.4K	﹤0.01%	1969
2014 Q4	$1.06M	Buy	5,570 +1,664	+43%	+$369K	﹤0.01%	2114
2014 Q3	$932K	Buy	3,906 +1,006	+35%	+$207K	﹤0.01%	2090
2014 Q2	$632K	Buy	2,900 +2,015	+228%	+$143K	﹤0.01%	2248
2014 Q1	$66K	Buy	+885	New	+$104K	﹤0.01%	2713
2013 Q4	–	Sell	-4,816	Closed	-$258K	–	2972
2013 Q3	$258K	Buy	4,816 +118	+3%	+$6.36K	﹤0.01%	2694
2013 Q2	$208K	Buy	+4,698	New	+$166K	﹤0.01%	2573

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Frank Company's PBYI Position: Q1 2016 in Review

Russell Frank Company reduced its Puma Biotechnology (PBYI) stake by 18% in Q1 2016, selling an estimated $1.74M and leaving 176,202 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #1308.

Russell Frank Company first reported a position in PBYI in Q2 2013 and has held it in 11 quarters since. The position peaked at $17.7M in Q3 2015. 119 funds tracked by Wall St. Rank hold PBYI as of Q1 2016.

Russell Frank Company held 176,202 shares of Puma Biotechnology worth $5.17M as of Q1 2016.
Russell Frank Company sold 38,544 Puma Biotechnology shares in Q1 2016, an estimated $1.74M.
Puma Biotechnology made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1308 holding.
Russell Frank Company first reported a position in Puma Biotechnology in Q2 2013 and has held it in 11 quarters since.
Russell Frank Company's Puma Biotechnology position peaked at $17.7M in Q3 2015.
119 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.